Symbotic Valuation
Is SYM * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SYM * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SYM * (MX$822.5) is trading above our estimate of fair value (MX$198.1)
Significantly Below Fair Value: SYM * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SYM *?
Other financial metrics that can be useful for relative valuation.
What is SYM *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$23.13b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.1x |
Enterprise Value/EBITDA | -29.3x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does SYM *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 3.4x | ||
GCARSO A1 Grupo Carso. de | 1.5x | 11.6% | Mex$295.7b |
IDEAL B-1 Impulsora del Desarrollo y el Empleo en América Latina. de | 4.1x | n/a | Mex$111.5b |
300124 Shenzhen Inovance TechnologyLtd | 4.8x | 16.9% | CN¥155.0b |
ALFA Alfa Laval | 3.1x | 5.3% | kr200.5b |
SYM * Symbotic | 2.7x | 34.1% | Mex$23.1b |
Price-To-Sales vs Peers: SYM * is good value based on its Price-To-Sales Ratio (2.7x) compared to the peer average (3.4x).
Price to Earnings Ratio vs Industry
How does SYM *'s PE Ratio compare vs other companies in the Global Machinery Industry?
Price-To-Sales vs Industry: SYM * is expensive based on its Price-To-Sales Ratio (2.7x) compared to the Global Machinery industry average (1.5x).
Price to Sales Ratio vs Fair Ratio
What is SYM *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 2.7x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate SYM *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$944.20 0% | 10.2% | Mex$1,083.51 | Mex$733.45 | n/a | 14 |
May ’25 | n/a | Mex$892.02 0% | 12.9% | Mex$1,068.45 | Mex$657.51 | n/a | 15 |
Apr ’25 | n/a | Mex$919.45 0% | 12.7% | Mex$1,108.11 | Mex$681.92 | n/a | 15 |
Mar ’25 | n/a | Mex$919.45 0% | 12.7% | Mex$1,108.11 | Mex$681.92 | n/a | 15 |
Feb ’25 | n/a | Mex$965.98 0% | 13.7% | Mex$1,204.61 | Mex$688.35 | n/a | 15 |
Jan ’25 | n/a | Mex$940.57 0% | 16.8% | Mex$1,203.34 | Mex$687.62 | n/a | 14 |
Dec ’24 | n/a | Mex$940.57 0% | 16.8% | Mex$1,203.34 | Mex$687.62 | n/a | 14 |
Nov ’24 | n/a | Mex$961.98 0% | 17.6% | Mex$1,258.66 | Mex$647.31 | n/a | 14 |
Oct ’24 | n/a | Mex$943.96 0% | 16.8% | Mex$1,220.17 | Mex$697.24 | n/a | 13 |
Sep ’24 | n/a | Mex$929.35 0% | 17.2% | Mex$1,192.82 | Mex$562.33 | n/a | 13 |
Aug ’24 | n/a | Mex$845.88 0% | 20.5% | Mex$1,095.98 | Mex$539.56 | n/a | 12 |
Jul ’24 | n/a | Mex$608.13 0% | 13.5% | Mex$855.60 | Mex$513.36 | n/a | 13 |
Jun ’24 | n/a | Mex$605.72 0% | 5.3% | Mex$641.35 | Mex$534.46 | n/a | 13 |
May ’24 | n/a | Mex$477.55 0% | 25.6% | Mex$627.50 | Mex$251.00 | n/a | 11 |
Apr ’24 | n/a | Mex$378.56 0% | 16.7% | Mex$458.61 | Mex$256.82 | n/a | 11 |
Mar ’24 | n/a | Mex$360.15 0% | 14.7% | Mex$443.26 | Mex$258.57 | n/a | 12 |
Feb ’24 | n/a | Mex$362.90 0% | 15.0% | Mex$451.91 | Mex$263.61 | n/a | 11 |
Jan ’24 | n/a | Mex$360.68 0% | 19.3% | Mex$464.48 | Mex$193.53 | n/a | 11 |
Dec ’23 | n/a | Mex$360.68 0% | 19.3% | Mex$464.48 | Mex$193.53 | n/a | 11 |
Nov ’23 | n/a | Mex$396.29 0% | 14.3% | Mex$475.55 | Mex$257.59 | n/a | 11 |
Oct ’23 | n/a | Mex$414.65 0% | 8.9% | Mex$478.02 | Mex$338.60 | n/a | 11 |
Sep ’23 | n/a | Mex$433.85 0% | 6.9% | Mex$491.15 | Mex$388.82 | n/a | 10 |
Aug ’23 | n/a | Mex$368.34 0% | 13.6% | Mex$491.12 | Mex$306.95 | n/a | 10 |
Jul ’23 | n/a | Mex$344.52 0% | 8.5% | Mex$380.57 | Mex$300.45 | n/a | 5 |
Jun ’23 | n/a | Mex$308.75 0% | 3.2% | Mex$318.71 | Mex$298.79 | n/a | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.